Steve Brozak, the Managing Partner and President of WBB Securities gave a comprehensive presentation about SARS-CoV-2 at Columbia University...Read More about WBB Securities President Steve Brozak Gives A SARS-CoV-2 Presentation Followed By A Q&A Session At Columbia University.
WBB Securities, sponsored a Demy-Colton Virtual Salon focused on the critical need for point-of-care...Read More about WBB Securities Sponsors Demy-Colton Virtual Salon “Sepsis: A Critical Healthcare Burden Needing Rapid Diagnoses to Improve Patient Outcomes”
Steve Brozak, Managing Partner and President of WBB Securities, LLC will moderate a live forum at Biotech Showcase on January 6, 2021.Read More about WBB Securities President Steve Brozak will moderate a Live Forum at Biotech Showcase today.
WBB Securities Acts As Co-Manager In a $85 Million Public Offering...Read More about WBB Securities Acts As Co-Manager In a $85 Million Public Offering, Pre-Funded Warrants and Warrants For SCYNEXIS, Inc.
WBB Securities acted as co-manager for a public offering of Omeros Corporation on August 11, 2020...Read More about WBB Securities Acts As Co-Manager In a $115.06 Million Public Offering For Omeros, Corporation.
Steve Brozak, President of WBB Securities appeared as an invited speaker at the Sachs Associates...Read More about WBB Securities President Steve Brozak Appeared as an Invited Speaker at The Sachs Associates Digital Novel Coronavirus Investment Forum
WBB Securities acted as co-manager to a transaction for Scynexis, Inc., is a biotechnology company primarily focused on drugs to treat infectious diseases.Read More about WBB Securities Acts As Co-Manager In $35 Million Follow-On Financing For Scynexis, Inc.
Executive Teams of Emerging Biotech Companies Present to Investor Community For Immediate Release September 6, 2019 SAN DIEGO, CA – WBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference. The Newsmakers[...]Read More about WBB Securities Sponsors BioCentury’s Annual NewsMakers Conference